Class Tries Again For Cert. In Cymbalta Withdrawal Suit
A proposed class of consumers who claim that Eli Lilly & Co. concealed the withdrawal risks associated with its antidepressant Cymbalta filed anew for class certification in California court on Monday,...To view the full article, register now.
Already a subscriber? Click here to view full article